We are happy and proud to announce the acquisition of all shares of Ivers-Lee Italia SpA by Omeia SA, with effect as of February 15, 2018.
Leaving the ILS holding, Ivers-Lee Italia SpA has changed name to Promeia SpA.
Promeia will continue the evolution to a more and more internationally active contract development, manufacturing and packaging service company for medical devices, cosmetics and food supplements. The company is focused on high-level niche products with elevated hygiene, safety and convenience requirements, and particularly specialized in flexible monodose packaging solutions.
Omeia SA is controlled by a group of Swiss and Italian professionals and investors, interested in the development of new technologies for the medical and cosmetic markets. From this business focus, the names of the companies derives, i.e. the two Greek words omorfiá (beauty – “OM”) and ygeía (health –“EIA”). Promeia will be in charge of the production (“PR”) activities for the group.
Marco Ghiringhelli, President of Omeia SA, comments: “We are very pleased to integrate Promeia SpA into our group of companies. Promeia has an experienced team of professionals who will move the business to the next level by creating strong added value for our customers.”
The team of Promeia SpA is looking forward to cooperating with you.
For further information please contact us:
Reason for interesting